Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Twenty-seven patients with cystic fibrosis completed a controlled trial comparing the effects of an inhaled mucolytic drug, sodium-2-mercaptoethane sulphonate (Mistabron, UCB Pharmaceutical Division, Brussels, Belgium), with inhaled iso-osmolar hypertonic saline. As a group the 22 patients with chro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Weller, P H, Ingram, D, Preece, M A, Matthew, D J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1980
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC471218/
https://ncbi.nlm.nih.gov/pubmed/6767295
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia